(Q39999387)

16 September 2017

Reflections on the white plague (English)

1 reference

16 September 2017

1

1 reference

16 September 2017

Jim Huggett

3

0 references

Peter Mwaba

series ordinal

2

object named as

Peter Mwaba

1 reference

16 September 2017

4

Nathan Kapata

1 reference

16 September 2017

Duncan Chanda

5

1 reference

PubMed ID

19246023

16 September 2017

John Grange

series ordinal

6

1 reference

16 September 2017

1 March 2009

1 reference

Lancet Infectious Diseases

16 September 2017

1 reference

16 September 2017

9

1 reference

16 September 2017

3

1 reference

16 September 2017

197-202

1 reference

Confronting the scientific obstacles to global control of tuberculosis

16 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970045-3

7 January 2021

Short-course chemotherapy for tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970045-3

7 January 2021

Short-course chemotherapy of tuberculosis. Hail Britannia (and friends)!

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970045-3

7 January 2021

The U-shaped curve of concern

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970045-3

7 January 2021

Resurgent tuberculosis in New York City. Human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970045-3

7 January 2021

The global tuberculosis situation and the new control strategy of the World Health Organization

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970045-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970045-3

1 reference

7 January 2021

Medical scientism: good practice or fatal error?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970045-3

7 January 2021

Geography, ecology and emerging infectious diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970045-3

7 January 2021

Directly observed therapy and treatment adherence

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970045-3

7 January 2021

Improving tuberculosis control: an interdisciplinary approach

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970045-3

7 January 2021

Progress of DOTS in global tuberculosis control

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970045-3

7 January 2021

Financial resources required for tuberculosis control to achieve global targets set for 2015.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970045-3

7 January 2021

Nihilism and pragmatism in tuberculosis control

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970045-3

7 January 2021

Tuberculosis--the tide can be turned, the battle can be won

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970045-3

7 January 2021

Doing something about tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970045-3

7 January 2021

Changing funding patterns in tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970045-3

7 January 2021

New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970045-3

7 January 2021

New tools and emerging technologies for the diagnosis of tuberculosis: part II. Active tuberculosis and drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970045-3

7 January 2021

A systematic review of rapid diagnostic tests for the detection of tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970045-3

7 January 2021

Tuberculosis: vaccines in the pipeline

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970045-3

7 January 2021

Preclinical study of new TB drugs and drug combinations in mouse models

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970045-3

7 January 2021

Emerging drugs for active tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970045-3

7 January 2021

Preclinical testing of new drugs for tuberculosis: current challenges

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970045-3

7 January 2021

Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970045-3

7 January 2021

Structure-based design of a novel class of potent inhibitors of InhA, the enoyl acyl carrier protein reductase from Mycobacterium tuberculosis: a computer modelling approach

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970045-3

7 January 2021

Tuberculosis and the poverty-disease cycle

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970045-3

7 January 2021

10.1016/S1473-3099(09)70045-3

Identifiers

DOI

1 reference

16 September 2017

1 reference

PubMed ID

19246023